Moxifloxacin for community-acquired pneumonia [3] (multiple letters)

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 1, 2003, Pages 444-445

  Rijnders, Bart J A ^a   Finch, Roger ^b   Schürmann, Dirk ^c   Kubin, Rolf ^d   Collins, Owen ^e   McGivern, Julie ^e   Izquierdo, Jose L ^f   Ogundare, F William ^h   Höffken, Gert ^g  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^c HUMBOLDT UNIVERSITY   (Germany)

^d BAYER AG   (Germany)

^e Bayer plc UK   (United Kingdom)

^f HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^g UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CLARITHROMYCIN; MOXIFLOXACIN;

COMMUNICABLE DISEASE; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; INTENSIVE CARE; LETTER; PENICILLIN RESISTANCE; PNEUMONIA; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; COMMUNITY-ACQUIRED INFECTIONS; FLUOROQUINOLONES; HUMANS; INTENSIVE CARE UNITS; PNEUMONIA; QUINOLINES; RANDOMIZED CONTROLLED TRIALS;

EID: 0037226388     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.1.444-445.2003     Document Type: Letter

References (0)